Alaunos Therapeutics, Inc. Increase (Decrease) in Other Operating Liabilities
Alaunos Therapeutics, Inc. (TCRT) reported Increase (Decrease) in Other Operating Liabilities of $7.00 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2019-11-07
- Alaunos Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2019-09-30 was $40.00K.
- Alaunos Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2019-06-30 was -$3.00K.
- Alaunos Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2019-03-31 was -$30.00K.
- Alaunos Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2013-12-31 was $0.00.
- Alaunos Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2013 was $20.00K.
- Alaunos Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2012 was $0.00.
- Alaunos Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2011 was $0.00.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month | Increase (Decrease) in Other Operating Liabilities 121 month | Increase (Decrease) in Other Operating Liabilities 124 month | Increase (Decrease) in Other Operating Liabilities 127 month |
|---|---|---|---|---|---|---|---|
| 2019-09-30 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $37.00K derived: sum of 2 quarters · filed 2019-11-07 | $7.00K 10-Q · filed 2019-11-07 | ||||
| 2019-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$33.00K 10-Q · filed 2019-08-08 | |||||
| 2019-03-31 | -$30.00K 10-Q · filed 2019-05-08 | ||||||
| 2014-03-31 | $20.00K 10-Q · filed 2014-05-08 | ||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $20.00K 10-K · filed 2014-03-03 | $20.00K 10-K · filed 2014-03-03 | ||||
| 2013-09-30 | $20.00K 10-Q · filed 2013-10-22 | $20.00K 10-Q · filed 2013-10-22 | |||||
| 2012-12-31 | $0.00 10-K · filed 2014-03-03 | ||||||
| 2011-12-31 | $0.00 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |